On September 2, 2021 Instil Bio, Inc. ("Instil") (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, reported that company management will participate in two upcoming investor conferences in September (Press release, Instil Bio, SEP 2, 2021, View Source [SID1234587175]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference
Fireside Chat: Thursday, September 9 at 2:00 p.m. ET

Baird’s 2021 Virtual Global Healthcare Conference
Company Presentation: Tuesday, September 14 at 5:30 p.m. ET

A live webcast, if recorded, of each presentation can be accessed under "News & Events" in the Investors section of the Company’s website at www.instilbio.com. The archived webcast will be available on the Company’s website shortly after the event.

On September 2, 2021 ChemoCentryx, Inc., (Nasdaq: CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences (Press release, ChemoCentryx, SEP 2, 2021, View Source [SID1234587194]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Virtual Wells Fargo Healthcare Conference
Fireside Chat Thursday, September 9 at 4:40 p.m. Eastern Time
H.C. Wainwright 23rd Annual Global Investment Conference
On-demand presentation available beginning Monday, September 13 at 7:00 a.m. Eastern Time
Live audio webcasts of the Wells Fargo fireside chat, as well as the on-demand H.C. Wainwright presentation can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. Replays of both the Wells Fargo and H.C. Wainwright presentations will be available on the Company’s website for two weeks following the respective presentation dates.

On September 2, 2021 Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) reported that management will present a company overview at the following virtual investor conferences (Press release, Ionis Pharmaceuticals, SEP 2, 2021, View Source [SID1234587210]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021
Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021
Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company’s website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

On September 2, 2021 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported it will participate in three upcoming conferences (Press release, Delcath Systems, SEP 2, 2021, View Source [SID1234595224]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021

Presentation Date and Time: On-demand beginning 9/13/2021 at 7:00 AM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23

Presentation Date and Time: 9/21/2021 12:25 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Cantor Fitzgerald Healthcare Conference: September 27th to 30th, 2021

Presentation Date and Time: 9/29/2021 4:40 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].

On September 2, 2021 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, reported that the Company will participate in Wells Fargo’s Virtual Healthcare Conference and H.C. Wainwright’s 23rd Annual Global Investment Conference being held virtually (Press release, Infinity Pharmaceuticals, SEP 2, 2021, View Source [SID1234587159]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details can be found below:

Wells Fargo Virtual Healthcare Conference
Format: Fireside chat and 1-on-1 meetings
Date and Time: Fireside chat September 9 th at 2:40pm ET; 1-on-1 meetings September 9-10
Webcast Link: View Source
H.C. Wainwright Virtual 23rd Annual Global Investment Conference
Format: On demand presentation and 1-on-1 meetings
Date and Time: Presentation available Monday, September 13 th 7am ET; 1-on-1 meetings September 13-15
Registration Link
The presentations and archived webcasts can be accessed in the Investors/Media section of Infinity’s website at www.infi.com and will be available on Infinity’s website for 30 days following the event.